Navigation Links
Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona
Date:4/13/2012

SILVER SPRING, Md., April 13, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into an advertising and promotion agreement ("Agreement") with a major pro sports team based in the state of Arizona (the "Team") for the marketing of Clotamin.  The Agreement is part of new marketing initiatives to promote and launch Clotamin in 240 Walgreens throughout Arizona.

Under terms of the Agreement, HDS, in conjunction with Walgreens, will have the right to make use of the Team name and logo in connection with an in-store Clotamin promotion, including the prominent placement of counter point-of-sale (POS) displays in all Walgreens locations in the state of Arizona for the duration of the promotion – approximately five months, beginning on June 1, 2012. 

During the consumer promotion and advertising program, Clotamin will be featured at Team home games on signage and other marketing elements throughout the University of Phoenix Stadium in Glendale, Arizona.  Team fans will be encouraged to visit their local Walgreens location, pick-up an entry form at the Team vendor display, and register for the opportunity to experience a Team home game in the comfort of an exclusive private box.  One lucky winner each month (4 total) will receive a private box for a Team home game, including game tickets, VIP parking passes, and a food and beverage package for 16 guests.  Also included in the exclusive prize package experience is special personal appearance by the Team mascot/cheerleaders and 16 team gift bags. 

"Similar to our pro sports team deal to market Clotamin with Walgreens in Oregon, this new agreement in Arizona is designed to leverage our advertising capabilities to grow awareness and acceptance of Clotamin with strong endorsements and strategic sponsorships," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "The marketing combination of pharmacy powerhouse Walgreens and a highly-recognizable pro sports team is designed to allow us to quickly introduce Clotamin to a statewide audience of loyal customers and fans.  We look forward to working closely with Walgreens and the Team to make this a successful product launch and an unforgettable experience for our contest winners."

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Enters Agreement with UK Based Healthcare Firm to Introduce Clotamin to UK and European Union Countries
2. Sunpeaks Ventures Announces Letter of Intent to Export Clotamin to Top Russian Pharmacies
3. Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
4. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
5. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
6. Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
7. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
8. Sunpeaks Ventures to Participate in ECRM Conference and Expo
9. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
10. Sunpeaks Ventures Announces Clotamin available on Walgreens.com
11. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
Breaking Medicine News(10 mins):